US Department of Defense
The company's FDA-cleared autonomous ultrasound imaging system uses a probe to allow for imaging in resource-limited environments to support trauma medicine.
The Ellume COVID-19 Home Test was the first rapid self-test authorized by the FDA for the detection of COVID-19 in individuals with or without symptoms.
Bethesda, Maryland-based BrainScope, which has developed mobile, non-invasive devices that help medical professionals assess Traumatic Brain Injury (TBI), raised $2.